These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4376675)

  • 1. The involvement of calcium and angiotensin II in vascular reactivity to noradrenaline in renal/salt hypertension.
    Collis MG; Alps BJ
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):107-14. PubMed ID: 4376675
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased cardiovascular reactivity in renal infarction hypertension.
    Basso N; de la Riva IJ
    Acta Physiol Lat Am; 1974; 24(2):109-18. PubMed ID: 4375405
    [No Abstract]   [Full Text] [Related]  

  • 3. The renin-angiotensin system, dietary salt, and increased sensitivity to noradrenaline in mesenteric vasculature preparations from renal/salt hypertensive rats.
    Collis MG; Alps BJ
    Cardiovasc Res; 1976 Mar; 10(2):232-5. PubMed ID: 938990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular reactivity in the experimental hypertensive rat.
    Finch L
    Br J Pharmacol; 1971 May; 42(1):56-65. PubMed ID: 4397172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular reactivity to noradrenaline and angiotensin in normotensive, hypertensive and 6-hydroxydopamine treated rats.
    Anokbonggo WW
    West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):1-8. PubMed ID: 1023507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular reactivity to noradrenaline, potassium chloride, and angiotensin II in the rat perfused mesenteric vasculature preparation, during the development of renal hypertension.
    Collis MG; Alps BJ
    Cardiovasc Res; 1975 Jan; 9(1):118-26. PubMed ID: 1122505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of central cardiovascular centers in hypertension.
    Baum T; Shropshire AT
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):405-13. PubMed ID: 4326552
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the vasopressor effect and inactivation of angiotensin in essential and renal as well as experimental hypertension].
    Wernze H; Hosoda S; Schölkens B
    Arch Klin Med; 1968; 214(3):286-305. PubMed ID: 4300861
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension.
    Long DA; Mu W; Price KL; Roncal C; Schreiner GF; Woolf AS; Johnson RJ
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1248-54. PubMed ID: 16804104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental, acute renal hypertension and exogenous angiotensin II administration following premedication with the prostaglandin biosynthesis inhibitor indometacin].
    Schölkens BA
    Verh Dtsch Ges Inn Med; 1974; 80():285-8. PubMed ID: 4375905
    [No Abstract]   [Full Text] [Related]  

  • 11. Losartan prevents salt-induced hypertension in reduced renal mass rats.
    Kanagy NL; Fink GD
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1131-6. PubMed ID: 8509998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A contrast in vascular reactivity between two kinds of experimental hypertension studied by measurements of the critical opening pressure of tail vessels in the conscious rat.
    Darke AC; Gaskell P
    Bibl Anat; 1973; 12():429-36. PubMed ID: 4364113
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug modification of digital vascular reactivity to vasoactive substances.
    Naftchi NE; Mendlowitz M
    Bibl Anat; 1969; 10():137-44. PubMed ID: 4337055
    [No Abstract]   [Full Text] [Related]  

  • 14. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
    Campese VM; Wurgaft A; Safa M; Bianchi S
    J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenteric microcirculation in rats with experimental hypertension.
    Vacek L
    Bibl Anat; 1969; 10():359-60. PubMed ID: 4337057
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of somatostatin on blood pressure and plasma renin activity in the rat.
    Schölkens BA
    Arzneimittelforschung; 1978; 28(5):802-3. PubMed ID: 581959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on hypertension: I) The effects of angiotensin II and norepinephrine infusion on renal hemodynamics and renin angiotensin system in anesthetized dogs. II) The metabolism of 3H-DOPA in two kidney Goldblatt dogs (author's transl)].
    Kita T
    Nihon Jinzo Gakkai Shi; 1978 Aug; 20(8):931-41. PubMed ID: 713169
    [No Abstract]   [Full Text] [Related]  

  • 18. Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations.
    Tatchum-Talom R; Eyster KM; Martin DS
    Can J Physiol Pharmacol; 2005 May; 83(5):413-22. PubMed ID: 15897923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular reactivity of rats during the development of salt hypertension. II. the responses to adrenaline, noradrenaline and acetylcholine.
    Honoré LH; Gardner DL
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):183-91. PubMed ID: 5972311
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
    Takata Y; Doyle AE
    J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.